The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early age of onset and broad cancer spectrum persist in MSH6 and PMS2-associated Lynch syndrome.
 
Ying L Liu
Research Funding - AstraZeneca; Tesaro/GSK
 
Karen Anne Cadoo
Honoraria - OncLive
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; GlaxoSmithKline/Tesaro; MJH Life Sciences; MSD
Research Funding - AstraZeneca (Inst); MSD (Inst); Syndax (Inst)
 
Anna Maio
No Relationships to Disclose
 
Zalak Patel
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Erin E. Salo-Mullen
No Relationships to Disclose
 
Amanda Catchings
No Relationships to Disclose
 
Megha Ranganathan
No Relationships to Disclose
 
Sarah R. Kane
No Relationships to Disclose
 
Jinru Shia
No Relationships to Disclose
 
Robert A. Soslow
No Relationships to Disclose
 
Ozge Birsoy
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Jaclyn Frances Hechtman
Honoraria - Bayer; Illumina; WebMD
Consulting or Advisory Role - Axiom Healthcare Strategies; Bayer; Cor2Ed
Research Funding - Bayer; Boehringer Ingelheim; Lilly
 
Maria Isabel Carlo
Consulting or Advisory Role - Pfizer
Other Relationship - Prostate Cancer Foundation; Robert Wood Johnson Foundation
 
Michael Francis Walsh
No Relationships to Disclose
 
Arnold Markowitz
No Relationships to Disclose
 
Kenneth Offit
No Relationships to Disclose
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Allergan (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Novartis (I); Optos (I); Regeneron (I); Regenxbio (I)
 
Alicia Latham
Other Relationship - Conquer Cancer Foundation